CAMBRIDGE, Mass., June 18, 2025 /PRNewswire/ — Biobot Analytics, the leader in wastewater intelligence, today announced a new round of funding led by Valor Equity Partners. Alongside Valor, Biobot is also welcoming new investor Atreides Management, as well as participation from existing investors, including Hyperplane. The investment reflects strong ongoing support for Biobot’s mission to build a wastewater intelligence platform for healthcare and national security applications.
The capital will support the company’s expanding suite of wastewater intelligence offerings, enabling continued innovation in advanced analytics, product development, and partnerships across government and commercial sectors.
As part of this round, Biobot is pleased to welcome new board members:
They join Biobot’s cofounders and existing Board Directors, Dr. Mariana Matus and Newsha Ghaeli, in guiding the company’s long-term strategy.
“We are proud to be backed by some of the most forward-thinking investors in the tech industry,” said Dr. Mariana Matus, CEO of Biobot Analytics. “Their support and insight will be instrumental as we build a new category of health intelligence—using wastewater data to create a safer, healthier, and more resilient society.”
“Biobot is a category-defining company with a bold vision for the future of healthcare and biosecurity,” said Vivek Pattipati, Partner at Valor Equity Partners. “We’re excited to support the talented team at Biobot as they bring innovative new products to market.”
Founded at the Massachusetts Institute of Technology, Biobot Analytics pioneered wastewater-based epidemiology in cities. From tracking COVID-19 trends across hundreds of communities to detecting opioid use and other health indicators, Biobot’s technology empowers governments and organizations with critical data.
About Biobot Analytics
Biobot Analytics is the global leader in wastewater intelligence. By analyzing wastewater, Biobot delivers real-time, community-wide insights into population health, empowering governments and organizations to identify outbreaks, monitor behavioral trends, and prepare for emerging threats. Learn more at www.biobot.io.
SOURCE Biobot Analytics, Inc.
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…